Literature DB >> 8849130

[Renovascular hypertension due to unilateral renal artery stenosis with hypokalemic alkalosis, the salt-losing syndrome and reversible hyperechogenicity of the contralateral kidney. A study of 2 infants].

F Castelló Girona1, D Yeste Fernández, R Porta Ribera, G Enríquez Cívicos.   

Abstract

This report describes two infants with severe arterial hypertension secondary to unilateral renal artery stenosis which was manifested by polyuria, polydipsia, hypokalemic alkalosis, hyponatremia, increased natriuresis and increased plasma values of rennin and aldosterone. On sonographic examination, the contralateral non-stenotic kidney of both patients appeared enlarged and hyperechogenic mimicking parenchymal lesion. When the patients became normotensive, their sodium and potassium balance became normal and their contralateral non-stenotic kidney also became normal in size and echogenicity. The increase of the filtration and the natriuresis observed in the contralateral non-stenotic kidney of the patients with renovascular hypertension due to renal artery stenosis might be responsible for the hyperechogenicity. When the patients became normotensive, the filtration and excretion of sodium of the contralateral kidney also became normal and the increase of echogenicity also disappeared. The reversibility of the sonographic findings suggest a functional origin.

Entities:  

Mesh:

Year:  1996        PMID: 8849130

Source DB:  PubMed          Journal:  An Esp Pediatr        ISSN: 0302-4342


  2 in total

1.  Unilateral renal ischemia causing the hyponatremic hypertensive syndrome in children--more common than we think?

Authors:  M Gary Nicholls
Journal:  Pediatr Nephrol       Date:  2006-05-20       Impact factor: 3.714

2.  Hypertension and segmental renal infarction in children: apropos of two cases.

Authors:  Júlia Candel-Pau; Yolanda Castilla-Fernández; Alvaro Madrid-Aris; Ramón Vilalta-Cases; Luis E Lara-Moctezuma; Pilar García-Peña; Mercedes Pérez; José L Nieto-Rey
Journal:  Pediatr Nephrol       Date:  2008-02-21       Impact factor: 3.714

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.